This study was designed to delineate the relative frequency of CYP2C9 and VKORC1 polymorphisms known to affect warfarin response in the highly heterogeneous Israeli population.
Center for Translational Genetics, B. Rappaport Institute for Research in Medical Sciences, Faculty of Medicine, Technion-Israel Institute of Technology and Rambam Health Care Campus, Haifa, Israel.